Banyan Hill Publishing continues to produce popular newsletters covering finance and investment topics. Both new and experienced investors might find browsing the titles of the company’s newsletters worthwhile. The professionals behind the scenes work hard at crafting informative content. Paul Mampilly, a Senior Editor for Banyan Hill Publishing, puts great effort into delivering insightful information to subscribers. Mampilly’s unique commentary frequently garners media attention. Recently, Mampilly made the news by offering opinions on two areas of investing. Top industry websites covered his views in lengthy features.
In one article, readers discover Paul Mampilly isn’t someone wedded to the past. He feels investors shouldn’t overlook businesses involved with the futuristic “Internet of Things.” IoT technology may seem like a strange science-fiction concept to some. Truthfully, IoT is science-fact existing in the here and now. Life has been made easy by the integration of technology through internet-connected devices. The number of homes and businesses using IoT products continues to increase.
Mampilly believes the Internet of Things will continue to grow further in the coming years. After all, the world has become technology driven. Consumer demand means customers want more of the conveniences IoT delivers. In some cases, necessity boosts demand.
Investments in established businesses and startups involved with IoT could potentially deliver strong returns. Just be aware virtually all investments come with risks. Researching a company before making any investment decisions makes sense and reflects a prudent approach. Reading quality newsletters to discover what IoT businesses plan on producing sustainable technologies could help with decision making.
The Internet of Things isn’t the only investment-oriented topic Mampilly addressed in the online media. The Banyan Hill editor also discussed the investment potential of precision medicine.
Precision medicine focuses on presenting better treatment and care options designed for a specific individual. A patient’s DNA may be examined to come up with an appropriate treatment approach. Carefully looking at unique data and other factors allow healthcare professionals to make patient-specific determinations. Specially crafted precision medicine approaches may prove better than providing traditional “generic” care methods.
Various private sector entities play a role in precision medicine research and development. A biotech company represents one type of business commonly involved with precision medicine research. Imagine investing in a biotech company that goes on to make a huge medical breakthrough. Investors in the company could reap windfalls. As always, an investor does need to make the right decision about what particular company to place his/her investment funds. Mampilly invested in Amazon at an early stage. The online retail company wasn’t a giant then. The company grew tremendously proving Mampilly made a wise decision.
Reading about different types of investments, even for just general knowledge, helps create a savvy investor. Educating oneself about investments also assists with finding the most desirable option. For some, tech stocks may be the right choice. Others look towards precision medicine for profits. Selecting the appropriate investment based on an informed decision represents a smart approach. Mampilly’s newsletter tries to help those seeking investment information. His newsletter, Profits Unlimited, currently reaches 90,000 readers. The high subscriber number reveals scores of readers take Mampilly’s musings seriously. His track record for success with his personal investments and professional career path established his all-important credibility.